A 38-year-old man from Delhi with newly diagnosed pulmonary tuberculosis is started on standard first-line ATT (HRZE). After 2 months of treatment, sputum smear microscopy remains positive. Drug susceptibility testing (DST) is performed and reports resistance to both isoniazid and rifampicin. What is the most appropriate next step in management?